#PrideInResearch at the MCRC – HPV screening for all

For this year’s Manchester Pride, we recognise the huge support within the MCRC for our vision of Equality, Diversity and Inclusion (EDI) in education. Read More

Professor Tim Illidge awarded a Fellowship of The Academy of Medical Sciences

Professor Tim Illidge has been recognised for his contributions to radiotherapy and lymphoma research Read More

MCRC Director’s Update – May 2022

May 2022 sees us celebrate our REF research impact, set out our case for banning indoor tanning beds and celebrate PhD and Early Career Researchers from the MCRC and DCS. Read More

Indoor tanning ban would reduce melanoma deaths, show researchers

MCRC Director’s Update – April 2022

April 2022 sees us officially launch the new vision of the Cancer Research UK Manchester Centre and our aim of driving translational research from the lab to the clinic. Read More

MCRC Director’s Update – March 2022

Visiting leadership in Kenya, five more years of funding for the Cancer Research UK Manchester Centre, and a visit to Westminster to launch On Cancer close an eventful March for the MCRC. Read More

On Cancer Westminster Launch

On 3 March 2022, to mark the launch of On Cancer, Policy@Manchester organised a panel discussion in Westminster to spotlight the policy recommendations that could help improve the lives of patients impacted by cancer. Read More

The ALETHEIA framework in radiation oncology

Dr Marianne Aznar explains the ALETHEIA Framework, an AI toolkit developed by Rolls-Royce, and how it is being applied to radiation oncology Read More

MCRC-DCS Alumni Showcase

Manchester Cancer Research Centre and Division of Cancer Sciences clinical and non-clinical PhD alumni discuss their post-PhD career highlights and tips for current postgraduate researchers. Read More

New era for Kenyan healthcare begins

Representatives of the MCRC partnership were in Kenya for the 14th March to mark the development of a Comprehensive Cancer Care Services network. Read More

MCRC Director’s Update – February 2022

TARGET National, Stampede, and DETERMINE clinical trials, as well as activities from World Cancer Day and Equality Diversity and Inclusivity cap off February at the MCRC. Read More

Thomas Kedward

We speak to Thomas Kedward about his PhD and the use of proteogenomics to connect somatic mutations to signalling in 
breast cancer patient-derived organoids. Read More

Introducing On Cancer

Professor Rob Bristow outlines the importance of the On Cancer publication and engagement of policy makers alongside our unique research and technologies here in Manchester. Read More

Hadiyat Ogunlayi

We speak to Hadiyat Ogunlayi about breast cancer and her MB-PhD investigating the relationship between a stromal wound healing phenotype and breast density as a mechanism for breast cancer development. Read More